These changes do not translate into major alterations of CD8+ T cell effector functions in vitro and T cell-intrinsic loss of CDK6 does not impact on anti-viral and anti-tumor responses in vivo. This discrepancy might partially be due to the complex interference of CDK6 in the fine-tuning of IFN responses. This evidence concerns the gene CD8A and neoplasm.